These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11466376)

  • 1. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.
    Han Y; Kozel TR; Zhang MX; MacGill RS; Carroll MC; Cutler JE
    J Immunol; 2001 Aug; 167(3):1550-7. PubMed ID: 11466376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.
    Han Y; Riesselman MH; Cutler JE
    Infect Immun; 2000 Mar; 68(3):1649-54. PubMed ID: 10678984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining criteria for anti-mannan antibodies to protect against candidiasis.
    Cutler JE
    Curr Mol Med; 2005 Jun; 5(4):383-92. PubMed ID: 15977994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis.
    Han Y
    Int Immunopharmacol; 2010 Dec; 10(12):1526-31. PubMed ID: 20840836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.
    Nishiya CT; Boxx GM; Robison K; Itatani C; Kozel TR; Zhang MX
    Infect Immun; 2016 Feb; 84(2):386-94. PubMed ID: 26573736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis.
    Lee JH; Jang EC; Han Y
    Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis.
    Xin H; Cutler JE
    Infect Immun; 2006 Jul; 74(7):4310-21. PubMed ID: 16790805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity.
    Caesar-TonThat TC; Cutler JE
    Infect Immun; 1997 Dec; 65(12):5354-7. PubMed ID: 9393840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments.
    Taborda CP; Casadevall A
    J Immunol; 2001 Feb; 166(3):2100-7. PubMed ID: 11160261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.
    Zhang MX; Bohlman MC; Itatani C; Burton DR; Parren PW; St Jeor SC; Kozel TR
    Infect Immun; 2006 Jan; 74(1):362-9. PubMed ID: 16368991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
    Boxx GM; Kozel TR; Nishiya CT; Zhang MX
    Infect Immun; 2010 Mar; 78(3):1250-9. PubMed ID: 20028806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
    Xin H; Rosario-Colon JA; Eberle K
    mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response that protects against disseminated candidiasis.
    Han Y; Cutler JE
    Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis.
    Rudkin FM; Raziunaite I; Workman H; Essono S; Belmonte R; MacCallum DM; Johnson EM; Silva LM; Palma AS; Feizi T; Jensen A; Erwig LP; Gow NAR
    Nat Commun; 2018 Dec; 9(1):5288. PubMed ID: 30538246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
    Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
    Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Xin H
    Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.
    Zhang MX; Cutler JE; Han Y; Kozel TR
    Infect Immun; 1998 Dec; 66(12):6027-9. PubMed ID: 9826391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.